Key Insights Institutions' substantial holdings in Jade Biosciences implies that they have significant influence ...
The average one-year price target for Jade Biosciences (NasdaqCM:JBIO) has been revised to $19.38 / share. This is an increase of 13.43% from the prior estimate of $17.08 dated September 27, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback